Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Exner

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Circulation Research|April 6, 2002
Leptin induces endothelin-1 in endothelial cells in vitroPeter Quehenberger, Markus Exner, Raute Sunder-Plassmann, et al.
Thrombosis Research|March 12, 2004
The E-selectin S128R polymorphism is not a risk factor for coronary artery disease in patients with diabetes mellitus type 2Georg Endler, Markus Exner, Marianne Raith, et al.
Journal of the American Society of Nephrology : JASN|August 23, 2002
Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejectionHeinz Regele, Georg A Böhmig, Antje Habicht, et al.
Journal of Immunological Methods|April 2, 2003
Flow cytometry based detection of HLA alloantibody mediated classical complement activationMarkus Wahrmann, Markus Exner, Heinz Regele, et al.
Free Radical Research|June 20, 2007
Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOClHilde Laggner, Markus K Muellner, Sabine Schreier, et al.
Journal of Vascular Surgery|May 6, 2005
Association of neutrophils and future cardiovascular events in patients with peripheral artery diseaseMarkus Haumer, Jasmin Amighi, Markus Exner, et al.
Stroke|June 4, 2005
Prognostic impact of fibrinogen in carotid atherosclerosis: nonspecific indicator of inflammation or independent predictor of disease progression?Schila Sabeti, Markus Exner, Wolfgang Mlekusch, et al.
Thrombosis and Haemostasis|November 16, 2004
High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stentingMartin Schillinger, Markus Exner, Schila Sabeti, et al.
The Biochemical Journal|March 7, 2009
Hydrogen sulfide destroys lipid hydroperoxides in oxidized LDLMarkus K Muellner, Sabine M Schreier, Hilde Laggner, et al.
European Journal of Clinical Investigation|November 9, 2010
Polymorphism of the palladin gene and cardiovascular outcome in patients with atherosclerosisMatthias Hoke, Martin Schillinger, Petra Dick, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Circulation Research|April 6, 2002
Leptin induces endothelin-1 in endothelial cells in vitroPeter Quehenberger, Markus Exner, Raute Sunder-Plassmann, et al.
Thrombosis Research|March 12, 2004
The E-selectin S128R polymorphism is not a risk factor for coronary artery disease in patients with diabetes mellitus type 2Georg Endler, Markus Exner, Marianne Raith, et al.
Journal of the American Society of Nephrology : JASN|August 23, 2002
Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejectionHeinz Regele, Georg A Böhmig, Antje Habicht, et al.
Journal of Immunological Methods|April 2, 2003
Flow cytometry based detection of HLA alloantibody mediated classical complement activationMarkus Wahrmann, Markus Exner, Heinz Regele, et al.
Free Radical Research|June 20, 2007
Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOClHilde Laggner, Markus K Muellner, Sabine Schreier, et al.
Journal of Vascular Surgery|May 6, 2005
Association of neutrophils and future cardiovascular events in patients with peripheral artery diseaseMarkus Haumer, Jasmin Amighi, Markus Exner, et al.
Stroke|June 4, 2005
Prognostic impact of fibrinogen in carotid atherosclerosis: nonspecific indicator of inflammation or independent predictor of disease progression?Schila Sabeti, Markus Exner, Wolfgang Mlekusch, et al.
Thrombosis and Haemostasis|November 16, 2004
High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stentingMartin Schillinger, Markus Exner, Schila Sabeti, et al.
The Biochemical Journal|March 7, 2009
Hydrogen sulfide destroys lipid hydroperoxides in oxidized LDLMarkus K Muellner, Sabine M Schreier, Hilde Laggner, et al.
European Journal of Clinical Investigation|November 9, 2010
Polymorphism of the palladin gene and cardiovascular outcome in patients with atherosclerosisMatthias Hoke, Martin Schillinger, Petra Dick, et al.
Pageof 11